Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jun 27, 2016	SC TO-T/A	Amendment to a previously filed SC TO-T	Mergers & Acquisitions	View HTML 0001193125-16-632069.pdf 0001193125-16-632069.rtf 0001193125-16-632069.xls
Jun 29, 2016	SC TO-T/A	Amendment to a previously filed SC TO-T	Mergers & Acquisitions	View HTML 0001193125-16-636599.pdf 0001193125-16-636599.rtf 0001193125-16-636599.xls
Jul 06, 2016	SC TO-T/A	Amendment to a previously filed SC TO-T	Mergers & Acquisitions	View HTML 0001193125-16-642550.pdf 0001193125-16-642550.rtf 0001193125-16-642550.xls
Jul 12, 2016	SC TO-T/A	Amendment to a previously filed SC TO-T	Mergers & Acquisitions	View HTML 0001193125-16-645979.pdf 0001193125-16-645979.rtf 0001193125-16-645979.xls
Feb 23, 2009	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-09-034320.pdf 0001193125-09-034320.rtf 0001193125-09-034320.xls
Aug 10, 2012	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-12-348899.pdf 0001193125-12-348899.rtf 0001193125-12-348899.xls
Dec 20, 2013	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-13-481242.pdf 0001193125-13-481242.rtf 0001193125-13-481242.xls
Apr 01, 2014	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001445305-14-001240.pdf 0001445305-14-001240.rtf 0001445305-14-001240.xls
Jun 01, 2016	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-16-608925.pdf 0001193125-16-608925.rtf 0001193125-16-608925.xls
Sep 27, 2016	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001232524-16-000372.pdf 0001232524-16-000372.rtf 0001232524-16-000372.xls

Data provided by Kaleidoscope.